NCT04570969

Brief Summary

Liver donors have a significant risk to develop persistent and chronic pain around 20 to 30% affecting social and professional life (17%) up to 1 year after the surgery. To donate a part of liver is a beautiful gift reason why the pain relief must be improved. Meta-analysis showed that the best prevention against post operative chronic pain are the techniques blocking the pain signal (regional anaesthesia) Patients after liver donation are still in pain even in 2020 with the best multimodal analgesia medications. Erector sinae Plane Block (ESP) ESP will block the signal and improve the pain relief we hope to demonstrate that it will reduce the risk to develop post operative chronic pain and improve the quality of recovery and the quality of life after liver donation

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
24

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2020

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 20, 2020

Completed
10 days until next milestone

First Posted

Study publicly available on registry

September 30, 2020

Completed
1 month until next milestone

Study Start

First participant enrolled

November 1, 2020

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2023

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 25, 2024

Completed
Last Updated

November 15, 2022

Status Verified

November 1, 2022

Enrollment Period

3.1 years

First QC Date

September 20, 2020

Last Update Submit

November 11, 2022

Conditions

Outcome Measures

Primary Outcomes (2)

  • quality of pain relief at rest

    Visual analgesic score at rest

    from day 0 = day of surgery to day 180

  • quality of pain relief at mouvement

    Visual analgesic score at mouvement

    from day 0 = day of surgery to day 180

Secondary Outcomes (5)

  • Opioid consumption

    from day 0 to 30 days after the day of surgery

  • Duration of hospitalisation

    From day = 0 day of the surgery to day to discharge day 15 maximum

  • Quality of recovery

    1 month after surgery

  • Patient satisfaction

    1 month after the surgery

  • Quality of life (QOL) after donation

    1 months and 3 months after surgery

Study Arms (2)

standard of care

NO INTERVENTION

Peri-operative analgesia by opioids

Peri operative regional analgesia

EXPERIMENTAL

Peri-operative analgesia by Continuous bilateral Erector Spinae Catheters

Procedure: Erector spinae plane block

Interventions

Insertion of bilateral catheters in the intersfacia space of erector spinae muscle

Peri operative regional analgesia

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • age more than 18 and less than 61
  • Be volunteer to donate liver
  • agree to participate to study and consent signed
  • Risk of americain society of anesthesiologists score ASA from 1 to 5 score ASA must be 1 only

You may not qualify if:

  • Use of chronic opioid before the surgery
  • A diagnosis of chronic pain condition
  • Contra indication to perform ESP catheter
  • allergy to local anesthestics
  • Depression or psychiatric diagnosis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

VinMec INternational hospital

Hanoi, 100000, Vietnam

RECRUITING

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomized controlled prospective trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director of anesthesia and pain management - Anesthesiologist MD

Study Record Dates

First Submitted

September 20, 2020

First Posted

September 30, 2020

Study Start

November 1, 2020

Primary Completion

November 30, 2023

Study Completion

February 25, 2024

Last Updated

November 15, 2022

Record last verified: 2022-11

Data Sharing

IPD Sharing
Will not share

Locations